A
Andrew R. Barclay
Researcher at Royal Hospital for Sick Children
Publications - 36
Citations - 744
Andrew R. Barclay is an academic researcher from Royal Hospital for Sick Children. The author has contributed to research in topics: Parenteral nutrition & Population. The author has an hindex of 14, co-authored 35 publications receiving 641 citations. Previous affiliations of Andrew R. Barclay include University of Glasgow.
Papers
More filters
Journal ArticleDOI
Systematic Review: The Role of Breastfeeding in the Development of Pediatric Inflammatory Bowel Disease
Andrew R. Barclay,Richard K Russell,Michelle Wilson,W. Harper Gilmour,Jack Satsangi,David C. Wilson,David C. Wilson +6 more
TL;DR: In this article, the role of breast milk in the development of early onset inflammatory bowel disease (IBD) was assessed with a systematic review, finding that breast milk exposure had a significant protective effect (OR, 0.69; 95% CI, 051-0.94; P =.02) in developing early onset IBD.
Journal ArticleDOI
Probiotics for necrotizing enterocolitis: a systematic review.
TL;DR: The data appear to lend support to the use of oral probiotics for the prevention of NEC in preterm infants and those with VLBW, however, the data are insufficient to comment on their short- and long-term safety.
Journal ArticleDOI
Systematic review: medical and nutritional interventions for the management of intestinal failure and its resultant complications in children.
Andrew R. Barclay,Andrew R. Barclay,L. M. Beattie,Lawrence T. Weaver,David C. Wilson,David C. Wilson +5 more
TL;DR: Aliment Pharmacol Ther 2011; 33: 175–184
Journal ArticleDOI
A retrospective study showing maintenance treatment options for paediatric CD in the first year following diagnosis after induction of remission with EEN: supplemental enteral nutrition is better than nothing!
Hazel Duncan,Elaine Buchanan,Tracey Cardigan,Vikki Garrick,Lee Curtis,Paraic McGrogan,Andrew R. Barclay,Richard K. Russell +7 more
TL;DR: A sub group of patients can continue MEN as a maintenance treatment and this seems a useful strategy, especially in those who are not commencing azathioprine.
Journal ArticleDOI
The epidemiology of anemia in pediatric inflammatory bowel disease: prevalence and associated factors at diagnosis and follow-up and the impact of exclusive enteral nutrition.
Konstantinos Gerasimidis,Andrew R. Barclay,Alexandros Papangelou,Despoina Missiou,Elaine Buchanan,Cardigan Tracey,Rachel Tayler,Richard K Russell,Christine A. Edwards,Paraic McGrogan +9 more
TL;DR: Anemia is high at diagnosis and follow-up and should receive more attention from the clinical team; however, the focus should remain suppression of inflammatory process in active disease.